Royal Philips forms alliance with Corindus; Teleflex inks deal with GPO Amerinet;

> Corindus, a vascular robotic systems developer in Natick, MA, has formed a technology alliance with Royal Philips Electronics, which will gain a minority ownership stake in the company. Report

> Teleflex has announced a new three-year agreement with Amerinet, a national healthcare group purchasing organization. Amerinet selected Arrow Peripherally Inserted Central Catheters as part of a multi-source agreement. The new agreement begins May 1 and extends through April 30, 2014. Teleflex-Amerinet release

> The CEOs of two of the biggest medical device companies globally offered different opinions in recent months about the impact of an article about implanted cardioverter defibrillators and a Department of Justice investigation into these products. Story

> STAAR Surgical Company has received CE Mark approval for its Visian Implantable Collamer Lens V4c design. STAAR release

> Qualcomm, through its Wireless Reach initiative, the Egyptian Company for Mobile Services (Mobinil), Egypt's mobile operator, Click Diagnostics, along with the Egyptian Ministry of Health, supported by the Ministry of Communications and Information Technology, announced that they have launched a pilot program to test the technology framework which enables dermatologists to use Mobinil's 3G mobile network to diagnose skin conditions remotely. News

> Thousands of mourners have turned out for the public viewing for Indiana businessman and philanthropist Bill Cook. The founder of medical devicemaker the Cook Group died April 15 at age 80. Item

And Finally... Smith & Nephew is facing countercomplaints filed by some of the nine employees the it fired last month after the company claimed they were planning to resign together, start their own company and use the devicemaker's trade secrets. Report

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.